Session Details
[P096]Bioactive lipids
Thu. Nov 7, 2024 2:45 PM - 4:45 PM JST
Thu. Nov 7, 2024 5:45 AM - 7:45 AM UTC
Thu. Nov 7, 2024 5:45 AM - 7:45 AM UTC
Poster Room(G1-G4)
[2P-040]Analysis of tumor development by group XIIA secreted phospholipase A2
○Shohei Fujita1, Chika Mochizuki1, Yoshitaka Taketomi1, Makoto Murakami1,2 (1.Laboratory of Microenvironmental and Metabolic Health Science Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, 2.AMED-CREST)
キーテクノロジー:Lipidomics, FACS
[2P-041]Altered levels of bioactive sphingolipids and their metabolic enzymesin the prefrontal cortex of social defeat stress exposed mice.
○Katsuya Morito, Suzumi Kimura, Saki Fujisawa, Yuki Nishimura, Yusuke Hara, Kosuke Hajiri, Kentaro Takayama, Kazuki Nagasawa (Laboratory of Environmental Biochemistry, Kyoto Pharmaceutical University)
キーテクノロジー:LC-MS/MS
[2P-042]Sulfonated prostaglandins exhibit prostaglandin antagonism
○Katsuhisa Kurogi, Naoki Kodama, Shota Uchimitsu, Koshi Segawa, Yoichi Sakakibara (Department of Biochemistry and Applied Biosciences, University of Miyazaki)
キーテクノロジー:アンタゴニスト
[2P-043]Deficiency of microsomal prostaglandin E synthase (mPGES)-1 exacerbates irinotecan-induced gastrointestinal toxicity.
○Emiko Yoda, Kaito Murofushi, Miyabi Wada, Mana Okumo, Shuntaro Hara (Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University)
キーテクノロジー:Biochemistry
[2P-044]Physiological role of prostaglandins in early pancreatic development
○Ryunosuke Nakao1, Naoyuki Watanabe1, kyosiro Tuge1, Tomoaki Inazumi1, Atsushi Kawahara2, Soken Tsuchiya1, Yukihiko Sugimoto1 (1.Graduate School of Pharmaceutical Sciences, Kumamoto University, 2.Graduate School of Medical Science, University of Yamanashi)
キーテクノロジー:ゲノム編集
[2P-045]Functional interaction of contractile prostanoid receptors in uterine contraction
○Ryusei Takashima, Yuki Hirai, Toshiko Sugimoto, Tomoaki Inazumi, Soken Tsuchiya, Yukihiko Sugimoto (Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University)
キーテクノロジー:BRET
[2P-046]sPLA2-III deficiency ameliorates pulmonary fibrosis
○Sho Egawa1, Yoshitaka Taketomi1, Shigeyuki Shichino2, Kouji Matsushima2, Makoto Murakami1,3 (1.CDBIM, UTokyo, 2.RIBS, Tokyo Univ. of Sci., 3.AMED-CREST)
キーテクノロジー:リピドミクス、scRNA-seq